GeisterxFahrer
Bluelighter
I apologize in advance if I was repetitive.
I know of a few Long Acting opiates such as: Oxycontin, Opana ER, Exalgo, Fentanyl, and MS-Contin. I have a questions about the calculations used to convert from one long acting opioid to another. The example I will use here will be as if your doctor wanted to switch you from Oxycontin to Opana ER (Oxymorphone). The question that I will raise is about "incomplete cross tolerance".
Note: All estimates are in terms of Oral Bioavailability (according to Wikipedia)
First, we will start with the actual calculations and differences in dosing and potency between Oral Oxycodone vs. oral Oxymorphone. For instance, say you are currently prescribed 40mg of Oxycontin every 12 hours (oral BA of "up to ~87%"), and you are going switch to Opana ER (oral BA of ~10%); based on Opana's website, converting from a total daily dose of 80mg Oxycodone to Opana ER, you use the conversion ratio given on the Opana site of 2:1 (Implying that oral Oxymorphone is two times as potent as oral Oxycodone) and do the math: (80mg)(.5). This equation would yield a total dose of 40mg. Then we factor in the average 50% incomplete cross tolerance; which is the estimate doctors' generally use, and we end up with a resulting in a total daily dose of 20mg Opana ER (10mg every 12 hours)
Next, a little bit about the metabolism of Oxycodone. Based on this medical journal... In humans, Oxycodone's structure allows it to avoid serious first-pass metabolism. It was found that cytochrome P450(CYP)3A mediated the N-demethylation of Oxycodone into (noroxycodone, noroxymorphone, and α-/β-noroxycodol) which accounted for ~45% and ~21% of the dose of Oxycodone: whereas it was shown that CYP2D6 mediated the O-demethylation of Oxycodone into (Oxymorphone, α-/β-Oxymorphol), and 6-keto-reduction (α-/β-Oxycodol) which were shown to account for ~11%, ~6% and ~8%, ~6% of the dose respectively. It was found that the Major metabolites were Noroxycodone and Noroxymorphone both of which have half-lives longer than Oxycodone itself.
Now, we do some conversions. Assuming that ~11% of an oral dose of Oxycodone is metabolized into Oxymorphone is correct, we can calculate that for each oral dose of 40mg of Oxycodone released over a period of 12 hours (at the assumed maximum oral BA of ~87%); ~38.4mg of Oxycodone is actually absorbed by the body to be used meaning that of that, ~4.22mg of the Oxycodone is demethylated into Oxymorphone and of that ~4.22mg of Oxymorphone, (based on a the 10% oral BA of Oxymorphone) only ~.42mg of this metabolized Oxymorphone is used by the body per 40mg of Oxycontin over 12 hours.
Although exact numbers vary from article to article, It has been determined that Oxycodone is ~1.5-2 times more potent than oral Morphine and that Oxymorphone is ~3 times more potent than morphine. Using a well known converter, it shows us that 10mg of orally administered Morphine (without adjusting for incomplete cross tolerance)= ~6.67mg of orally administered Oxycodone (~1.5 x more potent) and ~3.33mg of orally administered Oxymorphone (~3 x more potent). Based on this, it can be assumed that orally administered Oxymorphone is ~2 x more potent than orally administered Oxycodone (Not taking the BA of each into account). Note: we demonstrated the 2:1 ratio between Oral Oxymorphone and Oral Oxycodone above.
By replacing the single 40mg dose of Oxycontin with the adjusted 10mg Opana ER; (based on a 10% oral bioavailability) only ~1mg of Oxymorphone is actually used by the body over this 12 hour period meaning that two 10mg Opana ER tablets taken orally every 12 hours would produce ~2mg of active Oxymorphone over 24 hours. Whereas before the switch to Opana ER; based on our calculations, we were already essentially absorbing ~.84mg of Oxymorphone over a period of 24 hours already. This means that by switching from 80mg of Oxycontin a day to 20mg of Opana ER a day; over a period of 24 hours, the body's dose of absorbed Oxymorphone has gone up from ~.84mg to ~2mg. However, Oxycodone itself IS active on its own, and produces a little less than half of the new dose of Oxymorphone already; Why would anyone want to go from Oxycontin to Opana ER? Using the reverse 2:1 ratio again (and going by our converter again), 20mg of Opana ER over 24 hours would be approximately equal to 40mg of Oxycodone (again, not taking BA into account).
So my questions is essentially, WHY do doctors' use this "incomplete cross tolerance"? When I was switched in December from MS Contin to Opana ER, I went through terrible withdrawals.
On a side note:
It has been demonstrated that "Oxymorphone['s oral bioavailability can] increase [by] ~50% when taken with food and erratically with alcohol use."
I know of a few Long Acting opiates such as: Oxycontin, Opana ER, Exalgo, Fentanyl, and MS-Contin. I have a questions about the calculations used to convert from one long acting opioid to another. The example I will use here will be as if your doctor wanted to switch you from Oxycontin to Opana ER (Oxymorphone). The question that I will raise is about "incomplete cross tolerance".
Note: All estimates are in terms of Oral Bioavailability (according to Wikipedia)
- Oxycontin (Oxycodone) = "up to ~87%"
- Opana ER (Oxymorphone) = "~10%"
- MS-Contin (Morphine Sulfate) = "~25%"
First, we will start with the actual calculations and differences in dosing and potency between Oral Oxycodone vs. oral Oxymorphone. For instance, say you are currently prescribed 40mg of Oxycontin every 12 hours (oral BA of "up to ~87%"), and you are going switch to Opana ER (oral BA of ~10%); based on Opana's website, converting from a total daily dose of 80mg Oxycodone to Opana ER, you use the conversion ratio given on the Opana site of 2:1 (Implying that oral Oxymorphone is two times as potent as oral Oxycodone) and do the math: (80mg)(.5). This equation would yield a total dose of 40mg. Then we factor in the average 50% incomplete cross tolerance; which is the estimate doctors' generally use, and we end up with a resulting in a total daily dose of 20mg Opana ER (10mg every 12 hours)
Next, a little bit about the metabolism of Oxycodone. Based on this medical journal... In humans, Oxycodone's structure allows it to avoid serious first-pass metabolism. It was found that cytochrome P450(CYP)3A mediated the N-demethylation of Oxycodone into (noroxycodone, noroxymorphone, and α-/β-noroxycodol) which accounted for ~45% and ~21% of the dose of Oxycodone: whereas it was shown that CYP2D6 mediated the O-demethylation of Oxycodone into (Oxymorphone, α-/β-Oxymorphol), and 6-keto-reduction (α-/β-Oxycodol) which were shown to account for ~11%, ~6% and ~8%, ~6% of the dose respectively. It was found that the Major metabolites were Noroxycodone and Noroxymorphone both of which have half-lives longer than Oxycodone itself.
Now, we do some conversions. Assuming that ~11% of an oral dose of Oxycodone is metabolized into Oxymorphone is correct, we can calculate that for each oral dose of 40mg of Oxycodone released over a period of 12 hours (at the assumed maximum oral BA of ~87%); ~38.4mg of Oxycodone is actually absorbed by the body to be used meaning that of that, ~4.22mg of the Oxycodone is demethylated into Oxymorphone and of that ~4.22mg of Oxymorphone, (based on a the 10% oral BA of Oxymorphone) only ~.42mg of this metabolized Oxymorphone is used by the body per 40mg of Oxycontin over 12 hours.
Although exact numbers vary from article to article, It has been determined that Oxycodone is ~1.5-2 times more potent than oral Morphine and that Oxymorphone is ~3 times more potent than morphine. Using a well known converter, it shows us that 10mg of orally administered Morphine (without adjusting for incomplete cross tolerance)= ~6.67mg of orally administered Oxycodone (~1.5 x more potent) and ~3.33mg of orally administered Oxymorphone (~3 x more potent). Based on this, it can be assumed that orally administered Oxymorphone is ~2 x more potent than orally administered Oxycodone (Not taking the BA of each into account). Note: we demonstrated the 2:1 ratio between Oral Oxymorphone and Oral Oxycodone above.
By replacing the single 40mg dose of Oxycontin with the adjusted 10mg Opana ER; (based on a 10% oral bioavailability) only ~1mg of Oxymorphone is actually used by the body over this 12 hour period meaning that two 10mg Opana ER tablets taken orally every 12 hours would produce ~2mg of active Oxymorphone over 24 hours. Whereas before the switch to Opana ER; based on our calculations, we were already essentially absorbing ~.84mg of Oxymorphone over a period of 24 hours already. This means that by switching from 80mg of Oxycontin a day to 20mg of Opana ER a day; over a period of 24 hours, the body's dose of absorbed Oxymorphone has gone up from ~.84mg to ~2mg. However, Oxycodone itself IS active on its own, and produces a little less than half of the new dose of Oxymorphone already; Why would anyone want to go from Oxycontin to Opana ER? Using the reverse 2:1 ratio again (and going by our converter again), 20mg of Opana ER over 24 hours would be approximately equal to 40mg of Oxycodone (again, not taking BA into account).
So my questions is essentially, WHY do doctors' use this "incomplete cross tolerance"? When I was switched in December from MS Contin to Opana ER, I went through terrible withdrawals.
On a side note:
It has been demonstrated that "Oxymorphone['s oral bioavailability can] increase [by] ~50% when taken with food and erratically with alcohol use."
